Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Clinical trial NCT07284641 · RECRUITING

Trial details

NCT number: NCT07284641
Sponsor: Paul Szabolcs
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Common Variable Immunodeficiency (CVID)Primary Immune Regulatory Disorder Immune Dysregulation DiGeorge Syndrome STAT 1 Gain of Function STAT 3 Gain of Function Hypomorphic RAG1 Deficiency CD40 Ligand Deficiency Mendelian Susceptibility to Mycobacterial Disease GATA2 Associated Immunodeficiency CD40 Deficiency Hypomorphic RAG2 Deficiency

Start date: 2026-05-04
Primary completion: 2030-05-04
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.